125 related articles for article (PubMed ID: 37057371)
21. Influence of Lactobacillus reuteri, Bifidobacterium animalis subsp. lactis, and prebiotic inulin on dysbiotic dental biofilm composition ex vivo.
Colamarino AN; Johnson TM; Boudreaux DM; Dutner JM; Stancoven BW; Lincicum AR; Akers JA
J Periodontol; 2023 Jun; 94(6):793-804. PubMed ID: 36542391
[TBL] [Abstract][Full Text] [Related]
22. Comparison of two probiotics in follow-on formula:
Dekker J; Quilter M; Qian H
Benef Microbes; 2022 Oct; 13(4):341-354. PubMed ID: 36004715
[TBL] [Abstract][Full Text] [Related]
23. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice.
Wang J; Tang H; Zhang C; Zhao Y; Derrien M; Rocher E; van-Hylckama Vlieg JE; Strissel K; Zhao L; Obin M; Shen J
ISME J; 2015 Jan; 9(1):1-15. PubMed ID: 24936764
[TBL] [Abstract][Full Text] [Related]
24. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
25. Anti-obesity properties of the strain Bifidobacterium animalis subsp. lactis CECT 8145 in Zücker fatty rats.
Carreras NL; Martorell P; Chenoll E; Genovés S; Ramón D; Aleixandre A
Benef Microbes; 2018 Jun; 9(4):629-641. PubMed ID: 29695181
[TBL] [Abstract][Full Text] [Related]
26. Safety and the probiotic potential of Bifidobacterium animalis CP-9.
Tsai HY; Wang YC; Liao CA; Su CY; Huang CH; Chiu MH; Yeh YT
J Food Sci; 2022 May; 87(5):2211-2228. PubMed ID: 35347713
[TBL] [Abstract][Full Text] [Related]
27. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
[TBL] [Abstract][Full Text] [Related]
28. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial.
Lai H; Li Y; He Y; Chen F; Mi B; Li J; Xie J; Ma G; Yang J; Xu K; Liao X; Yin Y; Liang J; Kong L; Wang X; Li Z; Shen Y; Dang S; Zhang L; Wu Q; Zeng L; Shi L; Zhang X; Tian T; Liu X
Gut Microbes; 2023; 15(1):2197837. PubMed ID: 37078654
[TBL] [Abstract][Full Text] [Related]
29. Impact of coculturing Bifidobacterium animalis subsp. lactis HN019 with yeasts on microbial viability and metabolite formation.
Toh M; Liu SQ
J Appl Microbiol; 2017 Oct; 123(4):956-968. PubMed ID: 28833937
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.
de Almeida Silva Levi YL; Ribeiro MC; Silva PHF; Silva GA; de Souza Salvador SL; de Souza SLS; Casarin R; Júnior ABN; Júnior MT; Palioto DB; Honório HM; Messora MR; Furlaneto FAC
Clin Oral Investig; 2023 Jan; 27(1):387-398. PubMed ID: 36305963
[TBL] [Abstract][Full Text] [Related]
31. The Influence of a Bifidobacterium animalis Probiotic on Gingival Health: A Randomized Controlled Clinical Trial.
Kuru BE; Laleman I; Yalnızoğlu T; Kuru L; Teughels W
J Periodontol; 2017 Nov; 88(11):1115-1123. PubMed ID: 28753102
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant Probiotics of
Wang CH; Yen HR; Lu WL; Ho HH; Lin WY; Kuo YW; Huang YY; Tsai SY; Lin HC
Front Endocrinol (Lausanne); 2022; 13():754401. PubMed ID: 35299968
[TBL] [Abstract][Full Text] [Related]
33. Effect of Bifidobacterium lactis HN019 on inflammatory markers and oxidative stress in subjects with and without the metabolic syndrome.
Bernini LJ; Simão ANC; de Souza CHB; Alfieri DF; Segura LG; Costa GN; Dichi I
Br J Nutr; 2018 Sep; 120(6):645-652. PubMed ID: 30058513
[TBL] [Abstract][Full Text] [Related]
34. Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.
Salazar N; Binetti A; Gueimonde M; Alonso A; Garrido P; González del Rey C; González C; Ruas-Madiedo P; de los Reyes-Gavilán CG
Int J Food Microbiol; 2011 Jan; 144(3):342-51. PubMed ID: 21078530
[TBL] [Abstract][Full Text] [Related]
35. Effects of dietary Lactobacillus rhamnosus JCM1136 and Lactococcus lactis subsp. lactis JCM5805 on the growth, intestinal microbiota, morphology, immune response and disease resistance of juvenile Nile tilapia, Oreochromis niloticus.
Xia Y; Lu M; Chen G; Cao J; Gao F; Wang M; Liu Z; Zhang D; Zhu H; Yi M
Fish Shellfish Immunol; 2018 May; 76():368-379. PubMed ID: 29550602
[TBL] [Abstract][Full Text] [Related]
36. Bifidobacterium animalis subsp. lactis lkm512 Attenuates Obesity-Associated Inflammation and Insulin Resistance Through the Modification of Gut Microbiota in High-Fat Diet-Induced Obese Mice.
Ma L; Zheng A; Ni L; Wu L; Hu L; Zhao Y; Fu Z; Ni Y
Mol Nutr Food Res; 2022 Feb; 66(3):e2100639. PubMed ID: 34847296
[TBL] [Abstract][Full Text] [Related]
37. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
38. In vivo screening of multiple bacterial strains identifies Lactobacillus rhamnosus Lb102 and Bifidobacterium animalis ssp. lactis Bf141 as probiotics that improve metabolic disorders in a mouse model of obesity.
Le Barz M; Daniel N; Varin TV; Naimi S; Demers-Mathieu V; Pilon G; Audy J; Laurin É; Roy D; Urdaci MC; St-Gelais D; Fliss I; Marette A
FASEB J; 2019 Apr; 33(4):4921-4935. PubMed ID: 30596521
[TBL] [Abstract][Full Text] [Related]
39. Metagenomic Analysis Reveals a Mitigating Role for
Wu F; Fang B; Wuri G; Zhao L; Liu F; Zhang M
Nutrients; 2022 May; 14(10):. PubMed ID: 35631266
[TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome.
Bernini LJ; Simão AN; Alfieri DF; Lozovoy MA; Mari NL; de Souza CH; Dichi I; Costa GN
Nutrition; 2016 Jun; 32(6):716-9. PubMed ID: 27126957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
